Association of TNF-α -308 G > a and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis

International Urology and Nephrology

Volumn 46, Issue 7, 2014, Pages 1419-1425

  Sener, Elif Funda ^a   Taheri, Serpil ^a   Korkmaz, Keziban ^a   Zararsiz, Gokmen ^a   Serhatlioglu, Faruk ^a   Unal, Aydin ^a   Emirogullari, Omer Naci ^a   Ozkul, Yusuf ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Arteriovenous fistula; Cytokine; Hemodialysis; Polymorphism; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOSIS; VASCULAR ACCESS; ADVERSE EFFECTS; AGED; ARTERIOVENOUS SHUNT; GENETICS; MIDDLE AGED; PROMOTER REGION; RENAL REPLACEMENT THERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR PATENCY;

ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RENAL DIALYSIS; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR PATENCY;

EID: 84903444512     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0580-2     Document Type: Article

References (26)

1. Girndt M, Heine GH, Ulrich C et al (2007) Gene polymorphism association studies in dialysis: vascular access. Semin Dial 20:63-67
2. Sung SA, Ko GJ, Jo SK et al (2008) Interleukin-10 and tumor necrosis factor-α polymorphisms in vascular access failure in patients on hemodialysis: preliminary data in Korea. J Korean Med Sci 23:89-93
3. Sachdeva M, Hung A, Kovalchuk O et al (2012) The initial vascular access type contributes to inflammation in incident hemodialysis patients. Int J Nephrol 2012:917465
4. Astor BC, Eustace JA, Powe NR et al (2005) Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol 16:1449-1455 (Pubitemid 41716530)
5. Marcus RJ, Marcus DA, Sureshkumar KK et al (2007) Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome. Gend Med 4:193-204 (Pubitemid 350082735)
6. Brophy DF, Bukaveckas BL, Ferreira-Gonzales A et al (2009) A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis. Hemodial Int 13:19-26
7. Jaber BL, Rao M, Guo D et al (2004) Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 25:212-219 (Pubitemid 38232649)
8. Memoli B (1999) Cytokine production in haemodialysis. Blood Purif 17:149-158
9. Genctoy G, Altun B, Kiykim AA et al (2005) TNF Alpha-308 genotype and Renin-Angiotensin system in hemodialysis patients: an effect on inflammatory cytokine levels? Artif Organs 29:174-182
10. Stenvinkel P, Pecoits-Filho R, Lindholm B, For the DialGene Consortium (2005) Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial 18:322-330 (Pubitemid 41159583)
11. Lovati E, Richard A, Frey BM et al (2001) Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 60:46-54 (Pubitemid 32587538)
12. Tripathi G, Sharma RK, Baburaj VP et al (2008) Genetic risk factors for renal failure among north Indian ESRD patients. Clin Biochem 41:525-531
13. Dundar M, Kiraz A, Balta B et al (2013) The role of TNF-α and PAI-1 in familial mediterranean fever. Mod Rheumatol 23:140-145
14. Emirogullari EF, Saatci C, Unal A et al (2010) Prothrombin, factor-V Leiden, and plasminogen activator inhibitor type 1 gene polymorphisms in hemodialysis patients with/without arteriovenous fistula thrombosis. Int J Nephrol Urol 2:314-319
15. Yu ZY, Chen LS, Zhang LC, Zhou TB (2012) Meta-analysis of the relationship between ACE I/D gene polymorphism and endstage renal disease in patients with diabetic nephropathy. Nephrology (Carlton) 17:480-487
16. Koch W, Kastrati A, Mehilli J et al (2000) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 102:197-202 (Pubitemid 30451777)
17. Tang FY, Liu FY, Xie XW (2008) Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem 319:33-39
18. Navis G, Van Der Kleij FG, De Zeeuw D, De Jong PE (1999) Angiotensin-converting enzyme gene I/D polymorphism and renal disease. J Mol Med 77:781-791 (Pubitemid 30014052)
19. Zsom M, Fülöp T, Zsom L et al (2011) Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial Int 15:501-508
20. McLaughlin KJ, Harden PN, Ueda S et al (1996) The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 28:912-915 (Pubitemid 26365540)
21. Buraczynska M, Ksiazek P, Drop A et al (2006) Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant 21:979-983
22. Güngör Y, Kayataş M, Yildiz G et al (2011) The presence of PAI-1 4G/5G and ACE DD genotypes increases the risk of early-stage AVF thrombosis in hemodialysis patients. Ren Fail 33(2):169-175
23. Balakrishnan VS, Guo D, Rao M et al (2004) Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65:1449-1460 (Pubitemid 38406987)
24. Manchanda PK, Kumar A, Kaul A, Mittal RD (2006) Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India. Clin Chim Acta 370:152-157 (Pubitemid 44080178)
25. Ram S, Bass K, Abreo K et al (2003) Tumor necrosis factor-alpha- 308 gene polymorphism is associated with synthetic hemodialysis graft failure. J Investig Med 51:19
26. Horakova K, Chylkova A, Kolorz M et al (2012) Polymorphism G-308A in the promoter of the tumor necrosis factor-α gene and its association with the risk of venous thromboembolism. Blood Coagul Fibrinolysis 23:316-319